Joan Merrill to Ikaros Transcription Factor
                            
                            
                                This is a "connection" page, showing publications Joan Merrill has written about Ikaros Transcription Factor.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.290
         
        
        
     
 
    
        
        - 
            Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus. N Engl J Med. 2022 03 17; 386(11):1034-1045.
            
            
                Score: 0.193
             
- 
            Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet. 2012 Apr 06; 90(4):648-60.
            
            
                Score: 0.097